Isolierte Thoraxperfusion mit Chemofiltration (ITP-F) beim fortgeschrittenen und vorbehandelten nicht kleinzelligen Bronchialkarzinom

Karl Reinhard Aigner, Emir Selak, Isolated Thoracic Perfusion with Chemofiltration (ITP-F) for Advanced and Pre-treated Non-Small-Cell Lung Cancer Springer, Berlin, Heidelberg. pp. 321- 329 ,(2011) , 10.1007/978-3-642-18173-3_24

Rebecca M. Woodward, Martin L. Brown, Susan T. Stewart, Kathleen A. Cronin, David M. Cutler, The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF. Cancer. ,vol. 110, pp. 2511- 2518 ,(2007) , 10.1002/CNCR.23058

Thomas E. Stinchcombe, Mark A. Socinski, Treatment Paradigms for Advanced Stage Non-small Cell Lung Cancer in the Era of Multiple Lines of Therapy Journal of Thoracic Oncology. ,vol. 4, pp. 243- 250 ,(2009) , 10.1097/JTO.0B013E31819516A6

Giorgio Vittorio Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, Ulrich Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Goksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David Gandara, Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 26, pp. 3543- 3551 ,(2008) , 10.1200/JCO.2007.15.0375

David H Johnson, Louis Fehrenbacher, William F Novotny, Roy S Herbst, John J Nemunaitis, David M Jablons, Corey J Langer, Russell F DeVore III, Jacques Gaudreault, Lisa A Damico, Eric Holmgren, Fairooz Kabbinavar, Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 22, pp. 2184- 2191 ,(2004) , 10.1200/JCO.2004.11.022

Gregory J. Riely, Naiyer A. Rizvi, Mark G. Kris, Daniel T. Milton, David B. Solit, Neal Rosen, Emir Senturk, Christopher G. Azzoli, Julie R. Brahmer, Francis M. Sirotnak, Venkatraman E. Seshan, Margaret Fogle, Michelle Ginsberg, Vincent A. Miller, Charles M. Rudin, Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 27, pp. 264- 270 ,(2009) , 10.1200/JCO.2008.17.4656

Sanjaykumar Hapani, David Chu, Shenhong Wu, Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis Lancet Oncology. ,vol. 10, pp. 559- 568 ,(2009) , 10.1016/S1470-2045(09)70112-3

Tony S.K. Mok, Yi-Long Wu, Chong-Jen Yu, Caicun Zhou, Yuh-Min Chen, Li Zhang, Jorge Ignacio, Meilin Liao, Vichien Srimuninnimit, Michael J. Boyer, Marina Chua-Tan, Virote Sriuranpong, Aru W. Sudoyo, Kate Jin, Michael Johnston, Winsome Chui, Jin-Soo Lee, Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 27, pp. 5080- 5087 ,(2009) , 10.1200/JCO.2008.21.5541

Seiji Niho, Kaoru Kubota, Koichi Goto, Kiyotaka Yoh, Hironobu Ohmatsu, Ryutaro Kakinuma, Nagahiro Saijo, Yutaka Nishiwaki, First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study Journal of Clinical Oncology. ,vol. 24, pp. 64- 69 ,(2006) , 10.1200/JCO.2005.02.5825

Mark A. Socinski, Thomas E. Stinchcombe, Duration of First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Less Is More in the Era of Effective Subsequent Therapies Journal of Clinical Oncology. ,vol. 25, pp. 5155- 5157 ,(2007) , 10.1200/JCO.2007.13.4015